RT‐PCR can serve as a confirmation test in cancer types with a high mutational frequency of NTRK gene fusions and known partner genes (for example, an ETV6‐NTRK3 fusion), but is not recommended for other cancer types. Using NGS as a reconfirmation method in patients with negative results for RT‐PCR is recommended. This evidence concerns the gene ETV6 and cancer.